Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 < em > in Vitro < /em >

This study could inform development and application of protease inhibitors for optimized antiviral treatments of COVID-19.PMID:34097489 | DOI:10.1128/AAC.02680-20

Source: Antimicrobial Agents and Chemotherapy - June 7, 2021 Category: Microbiology Authors: Karen A Gammeltoft Yuyong Zhou Carlos R Duarte Hernandez Andrea Galli Anna Offersgaard Rui Costa Long V Pham Ulrik Fahn øe Shan Feng Troels K H Scheel Santseharay Ramirez Jens Bukh Judith M Gottwein Source Type: research